INTERNATIONAL PATENT: SHANGHAI BAO PHARMACEUTICALS CO., LTD., 上海宝济药业股份有限公司 FILES APPLICATION FOR "METHOD FOR REDUCING LEVEL OF IMMUNOGLOBULIN G IN SUBJECT"

GENEVA, Jan. 26 -- SHANGHAI BAO PHARMACEUTICALS CO., LTD. (No.28, Luoxin RoadBaoshan District, Shanghai 201908), 上海宝济药业股份有限公司 (中国上海市宝山区罗新路28号) filed a patent application (PCT/CN2025/108902) for "METHOD FOR REDUCING LEVEL OF IMMUNOGLOBULIN G IN SUBJECT" on Jul 16, 2025. With publication no. WO/2026/017088, the details related to the patent application was published on Jan 22, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): LIU,...